Ireland-based Covidien has received CE Mark approval for its Nellcor bedside SpO2 patient monitoring system, PM100N.

Covidien claims the system is the only commercially available bedside pulse oximetry (SpO2) monitor featuring home care and sleep study modes that complies with standards for medical electrical equipment used in the home health care environment.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system offers continuous monitoring of blood oxygenation (SpO2) and pulse rate, to help clinicians detect and respond to dangerous respiratory events, along with patient trend data to allow clinicians to evaluate their course of action.

During low patient perfusion, motion and other forms of signal interference, the new system offers speed and accuracy, as well as reliable pulse oximetry readings.

"The PM100N features SatSeconds Alarm Management technology that helps distinguish between serious and minor events."

The PM100N features SatSeconds Alarm Management technology that helps distinguish between serious and minor events.

See Also:

The technology is available only on Covidien patient monitors and helps in differentiating serious and minor events, while reducing clinically insignificant desaturation alarms.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Covidien said the monitor can also be password-protected to prevent lay users from inadvertently modifying settings.

Covidien respiratory and monitoring solutions chief medical officer Dr Scott Kelley said: "The availability of solutions to enable safe, quality care for patients in all settings, including the home, is something we are focused on at Covidien.

"This new system includes all of the leading Nellcor technology that clinicians have trusted for more than 30 years, with additional features that make it well suited to the home health care environment."

The Nellcor Bedside SpO2 Patient Monitoring System is available for sale in the European Economic Area (EEA), Australia and New Zealand.